+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Premature Ejaculation Treatment Market - Global Forecast 2026-2032- Product Image
Premature Ejaculation Treatment Market - Global Forecast 2026-2032- Product Image
New

Premature Ejaculation Treatment Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 197 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4968711
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The premature ejaculation treatment market is evolving as new clinical strategies, innovative products, and integrated models of care redefine competition and growth opportunities. Senior executives must proactively navigate regulatory, operational, and patient demand shifts to capture emerging value in this dynamic sector.

Market Snapshot: Premature Ejaculation Treatment Market Overview

The premature ejaculation treatment market is experiencing sustained expansion, with market value increasing from USD 3.52 billion in 2025 to USD 3.80 billion in 2026 and a projected CAGR of 8.04%. The industry is expected to attain USD 6.05 billion by 2032. This momentum is underpinned by heightened awareness among patients, broadening choices in clinical treatments, and stronger receptiveness toward integrative care strategies. Industry participants are actively adapting to regulatory evolution, wider reimbursement mechanisms, and increasing accessibility to new therapies. Each of these drivers is reshaping market positions, opening new partnership avenues, and intensifying the focus on differentiated offerings.

Scope & Segmentation

  • Treatment Modalities: Spanning nonpharmacological interventions like behavioral therapy and device-based treatments, as well as systemic pharmaceutical therapies such as phosphodiesterase inhibitors and selective serotonin reuptake inhibitors. Topical agents—including creams, sprays, and local anesthetics—supplement systemic treatments to enable tailored patient plans.
  • End-User Channels: Settings for diagnosis and treatment encompass clinics, hospitals, and home care. Each channel is influenced by unique reimbursement methods, care standards, and procurement practices, making channel-specific approaches relevant for market success.
  • Dosage Formats: Tablets, creams, and sprays meet variable patient needs, which are shaped by adherence concerns, recommendations from clinicians, and local market regulations. Customizing formats enhances user satisfaction and treatment adherence.
  • Geographic Regions: The Americas, Europe, Middle East & Africa, and Asia-Pacific regions demand distinct market approaches, driven by regulatory hurdles, payer requirements, and patient attitudes toward therapy options.
  • Technologies and Innovations: Developments include digital health platforms, telehealth-enabled care delivery, and advances in device engineering. Novel topical therapies add complexity, allowing for greater personalization and broadening patient reach in different care settings.

Key Takeaways for Senior Decision-Makers

  • Pursue integrated development to align product offerings with evolving clinical protocols and rising patient demand for holistic solutions.
  • Segment offerings strategically across treatment types, formats, and care settings to optimize both patient engagement and acceptance by payers.
  • Encourage collaboration between pharmaceutical and device developers to deliver more comprehensive treatment portfolios and achieve faster market entry.
  • Build agile manufacturing and procurement processes, enabling rapid adaptation to changing regulatory rules, tariff implications, and sourcing disruptions.
  • Localize market entry strategies by factoring in both regional regulations and the education needs of clinicians and patients for effective adoption.
  • Prioritize real-world evidence and economic outcomes to strengthen value demonstrations for both clinicians and payer organizations.

Tariff Impact: Navigating Operational and Sourcing Pressures

Recent tariff and trade policy adjustments are directly affecting the sourcing of ingredients, medical devices, and packaging. Companies are responding through nearshoring production, restructuring supplier agreements, and adjusting their therapy portfolios to emphasize higher-margin products. Increased administrative requirements and related costs now reward organizations with advanced compliance systems and agile manufacturing approaches. These changes drive greater evaluation by payers, heightening demand for transparent, outcomes-based contracts and robust evidence supporting therapeutic value.

Premature Ejaculation Treatment Market: Research Methodology & Data Sources

This report’s insights arise from a triangulated analysis using peer-reviewed clinical research, regulatory documents, expert interviews, and commercial supply chain intelligence. Data are sourced from randomized controlled trials, regulatory updates, and direct input from industry leaders, with cross-validation ensuring consistency and reliability.

Why This Report Matters

  • Provides leadership with strategies to refine product positioning, optimize channel distribution, and improve integration of therapies across the premature ejaculation treatment market.
  • Clarifies how operational modifications can enhance resilience against shifts in regulation and supply chain dynamics, supporting responsive and informed decision-making.
  • Supports benchmarking and competitive intelligence across innovation, evidence development, and key market moves for manufacturers, payers, and clinical stakeholders in all key regions.

Conclusion

Decision-makers who invest in patient-oriented strategies and agile, localized market access models position their organizations for sustainable growth and ongoing leadership within premature ejaculation care.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Premature Ejaculation Treatment Market, by Treatment Type
8.1. Non Pharmacological
8.1.1. Behavioral Therapy
8.1.1.1. Sensate Focus
8.1.1.2. Start Stop Technique
8.1.2. Devices
8.1.2.1. Constrictive Ring
8.1.2.2. Vibratory Stimulation
8.2. Pharmacological
8.2.1. Phosphodiesterase Inhibitors
8.2.1.1. Sildenafil
8.2.1.2. Tadalafil
8.2.2. Selective Serotonin Reuptake Inhibitors
8.2.2.1. Dapoxetine
8.2.2.2. Fluoxetine
8.2.3. Local Anesthetics
8.2.4. Combination Pills
9. Premature Ejaculation Treatment Market, by Dosage Form
9.1. Creams
9.2. Sprays
9.3. Tablets
10. Premature Ejaculation Treatment Market, by Route of Administration
10.1. Oral
10.2. Topical
11. Premature Ejaculation Treatment Market, by Onset Type
11.1. Lifelong Premature Ejaculation
11.2. Acquired Premature Ejaculation
12. Premature Ejaculation Treatment Market, by Treatment Accessibility
12.1. Prescription-based
12.2. Over-the-Counter (OTC)
13. Premature Ejaculation Treatment Market, by End User
13.1. Clinics
13.2. Home Care
13.3. Hospitals
14. Premature Ejaculation Treatment Market, by Distribution Channel
14.1. Online
14.2. Offline
15. Premature Ejaculation Treatment Market, by Region
15.1. Americas
15.1.1. North America
15.1.2. Latin America
15.2. Europe, Middle East & Africa
15.2.1. Europe
15.2.2. Middle East
15.2.3. Africa
15.3. Asia-Pacific
16. Premature Ejaculation Treatment Market, by Group
16.1. ASEAN
16.2. GCC
16.3. European Union
16.4. BRICS
16.5. G7
16.6. NATO
17. Premature Ejaculation Treatment Market, by Country
17.1. United States
17.2. Canada
17.3. Mexico
17.4. Brazil
17.5. United Kingdom
17.6. Germany
17.7. France
17.8. Russia
17.9. Italy
17.10. Spain
17.11. China
17.12. India
17.13. Japan
17.14. Australia
17.15. South Korea
18. United States Premature Ejaculation Treatment Market
19. China Premature Ejaculation Treatment Market
20. Competitive Landscape
20.1. Market Concentration Analysis, 2025
20.1.1. Concentration Ratio (CR)
20.1.2. Herfindahl Hirschman Index (HHI)
20.2. Recent Developments & Impact Analysis, 2025
20.3. Product Portfolio Analysis, 2025
20.4. Benchmarking Analysis, 2025
20.5. Church & Dwight Co., Inc.
20.6. Menarini Group
List of Figures
FIGURE 1. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL PREMATURE EJACULATION TREATMENT MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ONSET TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT ACCESSIBILITY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 15. CHINA PREMATURE EJACULATION TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY BEHAVIORAL THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY BEHAVIORAL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY BEHAVIORAL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SENSATE FOCUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SENSATE FOCUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SENSATE FOCUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY START STOP TECHNIQUE, BY REGION, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY START STOP TECHNIQUE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY START STOP TECHNIQUE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY CONSTRICTIVE RING, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY CONSTRICTIVE RING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY CONSTRICTIVE RING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY VIBRATORY STIMULATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY VIBRATORY STIMULATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY VIBRATORY STIMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE INHIBITORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE INHIBITORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE INHIBITORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SILDENAFIL, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SILDENAFIL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SILDENAFIL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TADALAFIL, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TADALAFIL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TADALAFIL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DAPOXETINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DAPOXETINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DAPOXETINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY FLUOXETINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY FLUOXETINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY FLUOXETINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY LOCAL ANESTHETICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY LOCAL ANESTHETICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY LOCAL ANESTHETICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COMBINATION PILLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COMBINATION PILLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COMBINATION PILLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY CREAMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY CREAMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY CREAMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SPRAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SPRAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SPRAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TABLETS, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TABLETS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TABLETS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ONSET TYPE, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY LIFELONG PREMATURE EJACULATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY LIFELONG PREMATURE EJACULATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY LIFELONG PREMATURE EJACULATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ACQUIRED PREMATURE EJACULATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ACQUIRED PREMATURE EJACULATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ACQUIRED PREMATURE EJACULATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT ACCESSIBILITY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PRESCRIPTION-BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PRESCRIPTION-BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PRESCRIPTION-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY OVER-THE-COUNTER (OTC), BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY OVER-THE-COUNTER (OTC), BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY OVER-THE-COUNTER (OTC), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 107. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 108. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2032 (USD MILLION)
TABLE 109. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2032 (USD MILLION)
TABLE 110. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
TABLE 111. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2032 (USD MILLION)
TABLE 112. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 113. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 114. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 115. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 116. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ONSET TYPE, 2018-2032 (USD MILLION)
TABLE 117. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT ACCESSIBILITY, 2018-2032 (USD MILLION)
TABLE 118. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 119. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 122. NORTH AMERICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2032 (USD MILLION)
TABLE 123. NORTH AMERICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
TABLE 125. NORTH AMERICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2032 (USD MILLION)
TABLE 126. NORTH AMERICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 127. NORTH AMERICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 128. NORTH AMERICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 129. NORTH AMERICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 130. NORTH AMERICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ONSET TYPE, 2018-2032 (USD MILLION)
TABLE 131. NORTH AMERICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT ACCESSIBILITY, 2018-2032 (USD MILLION)
TABLE 132. NORTH AMERICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 133. NORTH AMERICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 134. LATIN AMERICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. LATIN AMERICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 136. LATIN AMERICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2032 (USD MILLION)
TABLE 137. LATIN AMERICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2032 (USD MILLION)
TABLE 138. LATIN AMERICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
TABLE 139. LATIN AMERICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2032 (USD MILLION)
TABLE 140. LATIN AMERICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 141. LATIN AMERICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 142. LATIN AMERICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 143. LATIN AMERICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 144. LATIN AMERICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ONSET TYPE, 2018-2032 (USD MILLION)
TABLE 145. LATIN AMERICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT ACCESSIBILITY, 2018-2032 (USD MILLION)
TABLE 146. LATIN AMERICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 147. LATIN AMERICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2032 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2032 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2032 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ONSET TYPE, 2018-2032 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT ACCESSIBILITY, 2018-2032 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 162. EUROPE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. EUROPE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 164. EUROPE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2032 (USD MILLION)
TABLE 165. EUROPE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2032 (USD MILLION)
TABLE 166. EUROPE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
TABLE 167. EUROPE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2032 (USD MILLION)
TABLE 168. EUROPE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 169. EUROPE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 170. EUROPE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 171. EUROPE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 172. EUROPE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ONSET TYPE, 2018-2032 (USD MILLION)
TABLE 173. EUROPE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT ACCESSIBILITY, 2018-2032 (USD MILLION)
TABLE 174. EUROPE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 175. EUROPE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 176. MIDDLE EAST PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 177. MIDDLE EAST PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 178. MIDDLE EAST PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2032 (USD MILLION)
TABLE 179. MIDDLE EAST PREMATURE EJACULATION TREATMENT MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2032 (USD MILLION)
TABLE 180. MIDDLE EAST PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
TABLE 181. MIDDLE EAST PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2032 (USD MILLION)
TABLE 182. MIDDLE EAST PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 183. MIDDLE EAST PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 184. MIDDLE EAST PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 185. MIDDLE EAST PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 186. MIDDLE EAST PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ONSET TYPE, 2018-2032 (USD MILLION)
TABLE 187. MIDDLE EAST PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT ACCESSIBILITY, 2018-2032 (USD MILLION)
TABLE 188. MIDDLE EAST PREMATURE EJACULATION TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 189. MIDDLE EAST PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 190. AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 191. AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 192. AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2032 (USD MILLION)
TABLE 193. AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2032 (USD MILLION)
TABLE 194. AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
TABLE 195. AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2032 (USD MILLION)
TABLE 196. AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 197. AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 198. AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 199. AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 200. AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ONSET TYPE, 2018-2032 (USD MILLION)
TABLE 201. AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT ACCESSIBILITY, 2018-2032 (USD MILLION)
TABLE 202. AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 203. AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 204. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 205. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 206. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2032 (USD MILLION)
TABLE 207. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2032 (USD MILLION)
TABLE 208. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
TABLE 209. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2032 (USD MILLION)
TABLE 210. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 211. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 212. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 213. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 214. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ONSET TYPE, 2018-2032 (USD MILLION)
TABLE 215. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT ACCESSIBILITY, 2018-2032 (USD MILLION)
TABLE 216. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 217. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 218. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 219. ASEAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 220. ASEAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 221. ASEAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2032 (USD MILLION)
TABLE 222. ASEAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2032 (USD MILLION)
TABLE 223. ASEAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
TABLE 224. ASEAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2032 (USD MILLION)
TABLE 225. ASEAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 226. ASEAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 227. ASEAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 228. ASEAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 229. ASEAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ONSET TYPE, 2018-2032 (USD MILLION)
TABLE 230. ASEAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT ACCESSIBILITY, 2018-2032 (USD MILLION)
TABLE 231. ASEAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 232. ASEAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 233. GCC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 234. GCC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 235. GCC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2032 (USD MILLION)
TABLE 236. GCC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2032 (USD MILLION)
TABLE 237. GCC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
TABLE 238. GCC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2032 (USD MILLION)
TABLE 239. GCC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 240. GCC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 241. GCC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 242. GCC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 243. GCC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ONSET TYPE, 2018-2032 (USD MILLION)
TABLE 244. GCC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT ACCESSIBILITY, 2018-2032 (USD MILLION)
TABLE 245. GCC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 246. GCC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 247. EUROPEAN UNION PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 248. EUROPEAN UNION PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 249. EUROPEAN UNION PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2032 (USD MILLION)
TABLE 250. EUROPEAN UNION PREMATURE EJACULATION TREATMENT MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2032 (USD MILLION)
TABLE 251. EUROPEAN UNION PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
TABLE 252. EUROPEAN UNION PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2032 (USD MILLION)
TABLE 253. EUROPEAN UNION PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 254. EUROPEAN UNION PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 255. EUROPEAN UNION PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 256. EUROPEAN UNION PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 257. EUROPEAN UNION PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ONSET TYPE, 2018-2032 (USD MILLION)
TABLE 258. EUROPEAN UNION PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT ACCESSIBILITY, 2018-2032 (USD MILLION)
TABLE 259. EUROPEAN UNION PREMATURE EJACULATION TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 260. EUROPEAN UNION PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 261. BRICS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 262. BRICS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 263. BRICS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2032 (USD MILLION)
TABLE 264. BRICS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2032 (USD MILLION)
TABLE 265. BRICS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
TABLE 266. BRICS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2032 (USD MILLION)
TABLE 267. BRICS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 268. BRICS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 269. BRICS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 270. BRICS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 271. BRICS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ONSET TYPE, 2018-2032 (USD MILLION)
TABLE 272. BRICS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT ACCESSIBILITY, 2018-2032 (USD MILLION)
TABLE 273. BRICS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 274. BRICS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 275. G7 PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 276. G7 PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 277. G7 PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2032 (USD MILLION)
TABLE 278. G7 PREMATURE EJACULATION TREATMENT MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2032 (USD MILLION)
TABLE 279. G7 PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
TABLE 280. G7 PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2032 (USD MILLION)
TABLE 281. G7 PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 282. G7 PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 283. G7 PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 284. G7 PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 285. G7 PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ONSET TYPE, 2018-2032 (USD MILLION)
TABLE 286. G7 PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TREATMENT ACCESSIBILITY, 2018-2032 (USD MILLION)
TABLE 287. G7 PREMATURE EJACULATION TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 288. G7 PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 289.

Companies Mentioned

The key companies profiled in this Premature Ejaculation Treatment market report include:
  • AbbVie Inc.
  • Absorption Pharmaceuticals LLC
  • Alembic Pharmaceuticals Limited
  • AstraZeneca PLC
  • Bayer AG
  • Church & Dwight Co., Inc.
  • Cipla Limited
  • Endo International plc
  • Futura Medical plc
  • Lupin Limited
  • Mankind Pharma Ltd.
  • Menarini Group
  • Merck KGaA
  • Panacea Biotec Ltd.
  • Plethora Solutions Ltd.
  • Reckitt Benckiser Group plc
  • Regent Pacific Group Limited
  • Sandoz International GmbH
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceuticals Industries Ltd.
  • Torrent Pharmaceuticals Ltd.
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages197
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 3.8 Billion
Forecasted Market Value ( USD ) by 2032 $ 6.05 Billion
Compound Annual Growth Rate8.0%
Regions CoveredGlobal
No. of Companies Mentioned23

Related Topics

Related Reports

Premature Ejaculation Treatment Market Report 2025 - Product Image

Premature Ejaculation Treatment Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Premature Ejaculation Epidemiology Forecast 2025-2034 - Product Image

Premature Ejaculation Epidemiology Forecast 2025-2034

  • Report
  • 150 Pages
  • Global
From
Premature Ejaculation Treatment - Global Strategic Business Report - Product Image

Premature Ejaculation Treatment - Global Strategic Business Report

  • Report
  • 189 Pages
  • Global
From
Premature Ejaculation Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Premature Ejaculation Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 182 Pages
  • Global
From
Premature Ejaculation - Pipeline Insight, 2025 - Product Image

Premature Ejaculation - Pipeline Insight, 2025

  • Clinical Trials
  • 60 Pages
  • Global
From

About the Premature Ejaculation Drug Market

The Premature Ejaculation Drug market is a subset of the Sexual and Reproductive Health Drugs market. It is composed of drugs used to treat premature ejaculation, a condition in which a man ejaculates too quickly during sexual intercourse. These drugs are typically taken orally and work by increasing the time it takes for a man to ejaculate. Common side effects of these drugs include dizziness, headache, and nausea. The Premature Ejaculation Drug market is growing due to increased awareness of the condition and the availability of treatments. This has led to an increase in demand for these drugs, as well as an increase in research and development of new drugs. Some companies in the Premature Ejaculation Drug market include Pfizer, Eli Lilly, and Johnson & Johnson. These companies are involved in the research, development, and marketing of drugs to treat premature ejaculation. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.